| Date Filed | Type | Description |
| 08/04/2023 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 99,300 shares
@ $0 |
|
| 07/24/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/30/2022 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 2,000 shares
@ $3.0168, valued at
$6k
|
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/26/2021 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 120,000 options to buy
@ $5.45, valued at
$654k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 5,000 shares
@ $5.16, valued at
$25.8k
|
|
| 11/06/2020 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Exercised (in-or-at-the-money) 4,628 options to buy
@ $4, valued at
$18.5k
|
|
| 10/14/2020 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 60,000 options to buy
@ $7.44, valued at
$446.4k
|
|
| 09/18/2020 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Acquired 371,727 shares
@ $0 |
|
| 05/28/2020 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Bought 3,000 shares
@ $2.9797, valued at
$8.9k
|
|
| 03/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 9,255 shares
@ $4.11, valued at
$38k
Granted 6,942 options to buy
@ $4.8, valued at
$33.3k
Granted 4,628 options to buy
@ $4, valued at
$18.5k
|
|
| 08/19/2019 |
SC 13D
| Nijhawan Pardeep reports a 38.2% stake in EDESA BIOTECH, INC. |
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2019 |
SC 13D
| Nijhawan Pardeep reports a 37.9% stake in EDESA BIOTECH, inc. |
| 06/11/2019 |
4
| Nijhawan Pardeep (CEO) has filed a Form 4 on Edesa Biotech, Inc.|
Txns:
| Granted 507,129 shares
@ $0
Granted 1,988,424 shares
@ $0
Granted 211,506 shares
@ $0
Granted 44,823 options to buy
@ $0
Granted 1,529 options to buy
@ $0 |
|
| 06/11/2019 |
3
| Nijhawan Pardeep (CEO) has filed a Form 3 on Edesa Biotech, Inc. |